1. Home
  2. INLX vs SNTI Comparison

INLX vs SNTI Comparison

Compare INLX & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • SNTI
  • Stock Information
  • Founded
  • INLX 1996
  • SNTI 2016
  • Country
  • INLX United States
  • SNTI United States
  • Employees
  • INLX N/A
  • SNTI N/A
  • Industry
  • INLX EDP Services
  • SNTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • INLX Technology
  • SNTI Health Care
  • Exchange
  • INLX Nasdaq
  • SNTI Nasdaq
  • Market Cap
  • INLX 40.8M
  • SNTI 39.6M
  • IPO Year
  • INLX N/A
  • SNTI N/A
  • Fundamental
  • Price
  • INLX $9.87
  • SNTI $1.56
  • Analyst Decision
  • INLX
  • SNTI Strong Buy
  • Analyst Count
  • INLX 0
  • SNTI 2
  • Target Price
  • INLX N/A
  • SNTI $8.50
  • AVG Volume (30 Days)
  • INLX 2.3K
  • SNTI 107.2K
  • Earning Date
  • INLX 08-13-2025
  • SNTI 08-07-2025
  • Dividend Yield
  • INLX N/A
  • SNTI N/A
  • EPS Growth
  • INLX N/A
  • SNTI N/A
  • EPS
  • INLX N/A
  • SNTI N/A
  • Revenue
  • INLX $17,127,854.00
  • SNTI N/A
  • Revenue This Year
  • INLX $2.47
  • SNTI N/A
  • Revenue Next Year
  • INLX $7.72
  • SNTI $150.00
  • P/E Ratio
  • INLX N/A
  • SNTI N/A
  • Revenue Growth
  • INLX N/A
  • SNTI N/A
  • 52 Week Low
  • INLX $8.74
  • SNTI $1.46
  • 52 Week High
  • INLX $16.50
  • SNTI $16.94
  • Technical
  • Relative Strength Index (RSI)
  • INLX 38.26
  • SNTI 37.24
  • Support Level
  • INLX $8.98
  • SNTI $1.52
  • Resistance Level
  • INLX $10.17
  • SNTI $1.65
  • Average True Range (ATR)
  • INLX 0.42
  • SNTI 0.10
  • MACD
  • INLX 0.01
  • SNTI 0.03
  • Stochastic Oscillator
  • INLX 40.16
  • SNTI 50.00

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: